SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952
http://www.w3.org/2000/01/rdf-schema#comment
"Combined targeting of XPO1 and ERalpha in several tamoxifen-resistant cell lines and tumor xenografts with the XPO1 inhibitor Selinexor and tamoxifen restored tamoxifen sensitivity and prevented recurrence in vivo."
xsd:string
http://purl.uniprot.org/uniprot/#_A1D172DAA85E484B5D250065D5AD9309B7E2F69D552E3EEBF0A11F608C4D87B8913F5958DB193DCA36EA94EC0B92E2FA
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952
http://purl.uniprot.org/uniprot/H0Y4W6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952
http://purl.uniprot.org/uniprot/#_H0Y4W6-mappedCitation-27533791
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/481A8E16F894000604B66A50D0B80677AACEE23C0F1273B999B89B49CC9269011E654192A7C9563A042D3FF628A15952